AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ampco-Pittsburgh Corp.

$7.81 +$2.84 (+57.14%)
NYSE · 14 Sep 2026 20:00 UTC
Previous Close
$8.11
Day Range
$7.66$8.04
Year Range
$1.75$12.81
Market Cap
158.75M
AVG Volume
163.32K
Trailing/Forward PE
-2.66/-
PEG ratio
-0.03
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AP Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q2428.04M
26 Q1438.23M
25 Q4434.17M
25 Q3426.31M
25 Q2414.47M
25 Q1412.36M
24 Q4418.31M
24 Q3425.48M
24 Q2431.53M
24 Q1427.75M
Net Income (USD) · TTM
-80M-60M-40M-20M020M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AP Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-59.25M
26 Q1-68.08M
25 Q4-66.07M
25 Q3-5.3M
25 Q2-5.05M
25 Q14.3M
24 Q4438K
24 Q3-44.5M
24 Q2-41.73M
24 Q1-43.32M
Operating Income (USD) · TTM
-40M-20M020M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AP Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q28.89M
26 Q1739K
25 Q41.06M
25 Q37.23M
25 Q27.82M
25 Q115.94M
24 Q412.17M
24 Q3-34.58M
24 Q2-34.73M
24 Q1-36.48M
EBITDA (USD) · TTM
-40M-20M020M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AP EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2-24.63M
26 Q1-25.53M
25 Q4-23.79M
25 Q333.96M
25 Q232.66M
25 Q134.65M
24 Q431.16M
24 Q329.41M
24 Q228.91M
24 Q126.87M
Cash Flows (USD) · TTM
-20M-10M010M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AP Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2-3.99M
26 Q1-2.32M
25 Q4-8.06M
25 Q3-4.3M
25 Q2849K
25 Q1-3.34M
24 Q45.83M
24 Q32.46M
24 Q2-13.31M
24 Q1-14.41M
EPS (USD) · TTM
-4-3-2-10124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AP EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-2.93
26 Q1-3.36
25 Q4-3.26
25 Q3-0.25
25 Q2-0.24
25 Q10.22
24 Q40.02
24 Q3-2.26
24 Q2-2.12
24 Q1-2.2
Expenses (USD) · TTM
020M40M60M80MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AP Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q266.57M
26 Q149.36M
25 Q434.29M
25 Q323.56M
25 Q210.79M
25 Q112M
24 Q425.61M
24 Q328.39M
24 Q229.59M
24 Q133.28M
Shares Outstanding (USD) · TTM
-1M-750K-500K-250K0Buybacks (Repurchases)Stock-Based Compensation24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
AP Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q20
26 Q10
25 Q40
25 Q3-372K
25 Q2-372K
25 Q1-372K
24 Q4-718K
24 Q3-862K
24 Q2-862K
24 Q1-862K
Dividends (USD)
00.050.10.150.2Jan 15Apr 15Jul 15Oct 15Jan 16Apr 16Jul 16Oct 16Jan 17Apr 17
AP Dividends (USD) by quarter
PeriodDividends (USD)
Apr 170.09
Jan 170.09
Oct 160.09
Jul 160.09
Apr 160.09
Jan 160.18
Oct 150.18
Jul 150.18
Apr 150.18
Jan 150.18
Employee Count
05001K1.5K2K2016201720182019202020212022202320242025
AP Employee Count by quarter
PeriodEmployee Count
20251.43K
20241.63K
20231.7K
20221.56K
20211.49K
20201.53K
20191.67K
20181.92K
20171.94K
20161.92K
PE Ratio
050100150200med 34.34Nov 22Mar 23Jun 23Oct 23Jan 24Apr 25Aug 25
AP PE Ratio by quarter
PeriodPE Ratio
Aug 2515.9
Aug 2514.41
Jul 2516.55
Jul 2515.11
Jul 2514.51
Jul 2513.48
Jun 2513.76
Jun 2513.9
Jun 2514.23
Jun 2517.2
May 2514
May 2513.81
May 2512.74
May 25122.71
May 2598.08
Apr 2590.32
Apr 2589.86
Apr 2594.88
Apr 2587.13
Mar 2598.99
Mar 2598.99
Mar 2434.68
Mar 2434.41
Mar 2434.54
Mar 2433.31
Feb 2433.18
Feb 2434
Feb 2433.18
Feb 2434.95
Jan 2434.27
Jan 2433.59
Jan 2434.95
Jan 2435.64
Dec 2337.27
Dec 2335.91
Dec 2335.77
Dec 2336.18
Dec 2337.55
Nov 2328
Nov 2330.44
Nov 2329.88
Nov 2329.99
Oct 2330.44
Oct 2328.77
Oct 2328.77
Oct 2329.99
Sep 2329.22
Sep 2330.99
Sep 2331.88
Sep 2335.88
Sep 2336.99
Aug 2339.22
Aug 2334.88
Aug 2334.99
Aug 2318.17
Jul 2317.39
Jul 2317.98
Jul 2316.95
Jul 2314.94
Jun 2314.89
Jun 2313.68
Jun 2314
Jun 2314.94
Jun 2314.85
May 2314.8
May 2314.52
May 2312.74
May 2316.89
Apr 2317.12
Apr 2317.17
Apr 2316.55
Apr 2315.76
Mar 2313.89
Mar 2312.36
Mar 23124.5
Mar 23121.42
Mar 23141.48
Feb 23150.23
Feb 23144.06
Feb 23161.55
Feb 23165.15
Jan 23168.75
Jan 23161.03
Jan 23172.35
Jan 23144.57
Dec 22129.14
Dec 22137.88
Dec 22128.62
Dec 22149.71
Dec 22156.4
Nov 22174.92
Nov 22148.17
Mar 2268.33
Mar 2267.5
Feb 2266.66
Feb 2263.23
Feb 2263.02
Feb 2261.14
Jan 2257.08
Jan 2256.66
Free Cash Flow Yield
-40%-20%0%20%med -1.48%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
AP Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-2.5%
Sep 26-2.41%
Sep 26-2.25%
Aug 26-2.2%
Aug 26-2.22%
Aug 26-2.08%
Aug 26-1.2%
Jul 26-1.43%
Jul 26-1.4%
Jul 26-1.5%
Jul 26-1.46%
Jul 26-1.56%
Jun 26-1.23%
Jun 26-1.06%
Jun 26-0.97%
Jun 26-1.17%
May 26-1.01%
May 26-1.13%
May 26-1.06%
May 26-3.26%
May 26-3.8%
Apr 26-3.84%
Apr 26-4.21%
Apr 26-4.89%
Apr 26-5.56%
Mar 26-5.81%
Mar 26-5.81%
Mar 26-2.58%
Mar 26-2.57%
Feb 26-2.33%
Feb 26-2.4%
Feb 26-2.73%
Feb 26-3.13%
Jan 26-3.81%
Jan 26-3.55%
Jan 26-3.73%
Jan 26-4.11%
Jan 26-4.27%
Dec 25-4.57%
Dec 25-5.19%
Dec 25-5.85%
Dec 25-7.35%
Nov 25-8.2%
Nov 25-8.96%
Nov 25-8.63%
Nov 252.28%
Oct 252.01%
Oct 251.86%
Oct 252.06%
Oct 251.93%
Oct 251.9%
Sep 251.74%
Sep 251.72%
Sep 251.6%
Sep 251.54%
Aug 251.55%
Aug 251.41%
Aug 251.44%
Aug 25-4.89%
Aug 25-5.4%
Jul 25-4.7%
Jul 25-5.15%
Jul 25-5.36%
Jul 25-5.77%
Jun 25-5.65%
Jun 25-5.6%
Jun 25-5.47%
Jun 25-4.52%
May 25-5.56%
May 25-5.64%
May 25-6.11%
May 2510.85%
May 2513.58%
Apr 2514.75%
Apr 2514.82%
Apr 2514.04%
Apr 2515.29%
Mar 2513.46%
Mar 2513.46%
Mar 255.78%
Mar 256.38%
Feb 255.92%
Feb 256.16%
Feb 255.67%
Feb 256.1%
Jan 254.92%
Jan 254.59%
Jan 254.72%
Jan 255.4%
Jan 255.24%
Dec 245.98%
Dec 246.22%
Dec 246.16%
Dec 245.89%
Nov 245.7%
Nov 247.12%
Nov 247.42%
Nov 24-33.69%
Nov 24-38.09%
Oct 24-33.52%
Price to Sales
00.20.40.6med 0.14Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
AP Price to Sales by quarter
PeriodPrice to Sales
Sep 260.37
Sep 260.39
Sep 260.41
Aug 260.42
Aug 260.42
Aug 260.45
Aug 260.44
Jul 260.37
Jul 260.38
Jul 260.35
Jul 260.36
Jul 260.34
Jun 260.43
Jun 260.5
Jun 260.55
Jun 260.45
May 260.52
May 260.47
May 260.5
May 260.57
May 260.49
Apr 260.48
Apr 260.44
Apr 260.38
Apr 260.33
Mar 260.32
Mar 260.32
Mar 260.39
Mar 260.39
Feb 260.43
Feb 260.42
Feb 260.37
Feb 260.32
Jan 260.26
Jan 260.28
Jan 260.27
Jan 260.25
Jan 260.24
Dec 250.22
Dec 250.19
Dec 250.17
Dec 250.14
Nov 250.12
Nov 250.11
Nov 250.12
Nov 250.09
Oct 250.1
Oct 250.11
Oct 250.1
Oct 250.11
Oct 250.11
Sep 250.12
Sep 250.12
Sep 250.13
Sep 250.13
Aug 250.13
Aug 250.15
Aug 250.14
Aug 250.17
Aug 250.15
Jul 250.17
Jul 250.16
Jul 250.15
Jul 250.14
Jun 250.14
Jun 250.14
Jun 250.15
Jun 250.18
May 250.15
May 250.14
May 250.13
May 250.13
May 250.1
Apr 250.09
Apr 250.09
Apr 250.1
Apr 250.09
Mar 250.1
Mar 250.1
Mar 250.1
Mar 250.09
Feb 250.1
Feb 250.09
Feb 250.1
Feb 250.09
Jan 250.12
Jan 250.13
Jan 250.12
Jan 250.11
Jan 250.11
Dec 240.1
Dec 240.09
Dec 240.09
Dec 240.1
Nov 240.1
Nov 240.08
Nov 240.08
Nov 240.09
Nov 240.08
Oct 240.09
EV/EBITDA
46810med 5.64Jun 24Oct 24Jan 25May 25Aug 25Nov 25Mar 26
AP EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 268.59
Mar 268.59
Feb 269.1
Feb 268.96
Feb 268.32
Feb 267.72
Jan 267
Jan 267.24
Jan 267.07
Jan 266.76
Jan 266.64
Dec 256.45
Dec 256.11
Dec 255.84
Dec 255.4
Nov 255.22
Nov 255.09
Nov 255.14
Nov 255.11
Oct 255.26
Oct 255.37
Oct 255.23
Oct 255.32
Oct 255.34
Sep 255.46
Sep 255.48
Sep 255.6
Sep 255.66
Aug 255.64
Aug 255.81
Aug 255.78
Aug 255.58
Aug 255.4
Jul 255.66
Jul 255.49
Jul 255.41
Jul 255.28
Jun 255.32
Jun 255.34
Jun 255.38
Jun 255.75
May 255.35
May 255.32
May 255.19
May 255.5
May 255.16
Apr 255.05
Apr 255.04
Apr 255.11
Apr 255
Mar 255.17
Mar 255.17
Mar 255.64
Mar 255.5
Feb 255.6
Feb 255.55
Feb 255.67
Feb 255.56
Jan 255.89
Jan 256.01
Jan 255.96
Jan 255.74
Jan 255.79
Dec 245.59
Dec 245.54
Dec 245.55
Dec 245.61
Nov 245.66
Nov 245.37
Nov 245.32
Nov 245.93
Nov 245.78
Oct 245.94
Oct 245.92
Oct 245.79
Oct 245.8
Sep 245.97
Sep 246.02
Sep 245.93
Sep 245.85
Aug 245.96
Aug 245.93
Aug 245.8
Aug 245.64
Aug 245.74
Jul 245.82
Jul 245.9
Jul 245.79
Jul 245.2
Jun 245.21
Jun 245.24
Jun 245.41
Jun 245.54
May 245.61
May 245.75
May 245.75
May 245.64
May 245.74
Apr 245.8
Apr 245.85
Price/Operating Cashflow
050100150200med 8.04Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
AP Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2614.65
Sep 2615.21
Sep 2616.28
Aug 2616.62
Aug 2616.51
Aug 2617.58
Aug 2623.27
Jul 2619.67
Jul 2620.06
Jul 2618.74
Jul 2619.21
Jul 2617.98
Jun 2622.88
Jun 2626.42
Jun 2628.94
Jun 2623.88
May 2627.7
May 2624.86
May 2626.55
May 26183.7
May 26157.65
Apr 26155.99
Apr 26142.59
Apr 26122.57
Apr 26107.96
Mar 26103.29
Mar 26103.29
Mar 2627.37
Mar 2627.41
Feb 2630.26
Feb 2629.43
Feb 2625.88
Feb 2622.56
Jan 2618.5
Jan 2619.86
Jan 2618.93
Jan 2617.17
Jan 2616.51
Dec 2515.45
Dec 2513.59
Dec 2512.06
Dec 259.6
Nov 258.6
Nov 257.87
Nov 258.17
Nov 253.32
Oct 253.77
Oct 254.08
Oct 253.68
Oct 253.93
Oct 253.99
Sep 254.35
Sep 254.42
Sep 254.74
Sep 254.94
Aug 254.89
Aug 255.37
Aug 255.28
Aug 258.32
Aug 257.54
Jul 258.66
Jul 257.91
Jul 257.59
Jul 257.05
Jun 257.2
Jun 257.27
Jun 257.44
Jun 259
May 257.32
May 257.23
May 256.67
May 252.98
May 252.38
Apr 252.19
Apr 252.18
Apr 252.31
Apr 252.12
Mar 252.4
Mar 252.4
Mar 252.47
Mar 252.24
Feb 252.41
Feb 252.32
Feb 252.52
Feb 252.34
Jan 252.9
Jan 253.11
Jan 253.03
Jan 252.65
Jan 252.73
Dec 242.39
Dec 242.3
Dec 242.32
Dec 242.43
Nov 242.51
Nov 242.01
Nov 241.93
Nov 2414.98
Nov 2413.24
Oct 2415.05
Price to Book
0246med 0.78Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
AP Price to Book by quarter
PeriodPrice to Book
Sep 263.3
Sep 263.43
Sep 263.67
Aug 263.75
Aug 263.72
Aug 263.96
Aug 264.05
Jul 263.42
Jul 263.49
Jul 263.26
Jul 263.34
Jul 263.13
Jun 263.98
Jun 264.59
Jun 265.03
Jun 264.15
May 264.82
May 264.32
May 264.62
May 265.15
May 264.42
Apr 264.37
Apr 264
Apr 263.43
Apr 263.03
Mar 262.89
Mar 262.89
Mar 262.24
Mar 262.24
Feb 262.47
Feb 262.4
Feb 262.11
Feb 261.84
Jan 261.51
Jan 261.62
Jan 261.55
Jan 261.4
Jan 261.35
Dec 251.26
Dec 251.11
Dec 250.98
Dec 250.78
Nov 250.7
Nov 250.64
Nov 250.67
Nov 250.49
Oct 250.55
Oct 250.6
Oct 250.54
Oct 250.58
Oct 250.58
Sep 250.64
Sep 250.65
Sep 250.69
Sep 250.72
Aug 250.71
Aug 250.79
Aug 250.77
Aug 250.88
Aug 250.8
Jul 250.92
Jul 250.84
Jul 250.8
Jul 250.75
Jun 250.76
Jun 250.77
Jun 250.79
Jun 250.95
May 250.77
May 250.76
May 250.7
May 250.76
May 250.6
Apr 250.56
Apr 250.55
Apr 250.58
Apr 250.54
Mar 250.61
Mar 250.61
Mar 250.58
Mar 250.52
Feb 250.56
Feb 250.54
Feb 250.59
Feb 250.55
Jan 250.68
Jan 250.73
Jan 250.71
Jan 250.62
Jan 250.64
Dec 240.56
Dec 240.54
Dec 240.54
Dec 240.57
Nov 240.59
Nov 240.47
Nov 240.45
Nov 240.57
Nov 240.5
Oct 240.57
Ampco-Pittsburgh Corp.
AP
Stockpicker

Video analysis: AP

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: AP

Ampco-Pittsburgh: I'm Taking The Bait And Turning Bullish

seekingalpha.com · 14 Sep 2026

Ampco-Pittsburgh: I'm Taking The Bait And Turning Bullish

Ampco-Pittsburgh is upgraded to Buy as a turnaround accelerates, with demand and backlogs surging, especially in the Air and Liquid Processing segment. Despite rising net debt and thin liquidity, AP's backlog reached $358 million, with a book-to-bill ratio of 1.27x, signaling robust forward demand. Adjusted EBITDA margin improved to 9.49%, and incremental margins in ALP hit 55.4%, supporting reinvestment over debt repayment as the optimal capital allocation.

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia

gurufocus.com · 30 Aug 2026

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented results from the pivotal Phase 3 SHASTA-3 and SHASTA-4 studies of plozasiran in adults with sever

Ampco-Pittsburgh vs. NN: Which Industrial Stock Is the Better Buy?

zacks.com · 26 Aug 2026

Ampco-Pittsburgh vs. NN: Which Industrial Stock Is the Better Buy?

AP and NNBR are riding different industrial demand tailwinds, but which looks more compelling now? Let's dive in.

Ampco-Pittsburgh Stock Up Post Q2 Earnings, Orders Improve Sequentially

zacks.com · 14 Aug 2026

Ampco-Pittsburgh Stock Up Post Q2 Earnings, Orders Improve Sequentially

AP's second-quarter 2026 results show stronger profitability, improving orders and a growing backlog despite lower sales and negative free cash flow.

Ampco-Pittsburgh Corporation (AP) Q2 2026 Earnings Call Transcript

seekingalpha.com · 11 Aug 2026

Ampco-Pittsburgh Corporation (AP) Q2 2026 Earnings Call Transcript

Ampco-Pittsburgh Corporation (AP) Q2 2026 Earnings Call Transcript

Ampco-Pittsburgh Q2 Earnings Call Highlights

marketbeat.com · 11 Aug 2026

Ampco-Pittsburgh Q2 Earnings Call Highlights

Ampco-Pittsburgh NYSE: AP reported second-quarter 2026 net income of $1.5 million, or $0.07 per share, compared with a net loss of $7.3 million, or $0.36 per share, in the prior-year period, as restructuring actions and improved operating performance supported profitability.

Ampco-Pittsburgh Corporation Announces Second Quarter 2026 Results

businesswire.com · 11 Aug 2026

Ampco-Pittsburgh Corporation Announces Second Quarter 2026 Results

CARNEGIE, Pa.--(BUSINESS WIRE)--Ampco-Pittsburgh Corporation (the “Company” or “Ampco”) (NYSE: AP) announced financial results for its second quarter ended June 30, 2026 (“Second Quarter 2026”). “Our Second Quarter 2026 results reflect continued progress across the business as customer activity improved and the benefits of actions taken over the last year continued to build,” said Brett McBrayer, CEO of Ampco-Pittsburgh. “In Forged and Cast Engineered Products, order activity improved, particul.

Ampco-Pittsburgh Schedules Second Quarter 2026 Earnings Conference Call

businesswire.com · 3 Aug 2026

Ampco-Pittsburgh Schedules Second Quarter 2026 Earnings Conference Call

CARNEGIE, Pa.--(BUSINESS WIRE)--Ampco-Pittsburgh Corporation (NYSE: AP) will hold a conference call on Tuesday, August 11, 2026, at 8:30 a.m. Eastern Time (ET) to discuss its financial results for the second quarter ended June 30, 2026. If you would like to participate in the conference call, please register using the link below or by dialing 1-844-308-3408 at least five minutes before the 8:30 a.m. ET start time. We encourage participants to pre-register for the conference call using the follo.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.